BACKGROUND: Heavy menstrual bleeding is a leading cause of copper intrauterine device discontinuation. Thus, girls and women with heavy baseline menstrual bleeding may be at increased risk for early copper intrauterine device discontinuation. OBJECTIVE: Our objective was to assess if there was an association between baseline menstrual bleeding pattern prior to intrauterine device insertion and discontinuation rate at 12 months among study participants who chose copper intrauterine device at baseline. STUDY DESIGN: We performed a secondary analysis of the Contraceptive CHOICE Project, a prospective observational cohort study of 9256 girls and women offered no-cost contraception for 2e3 years. Included in our study were participants who chose copper intrauterine device for contraception and for whom method continuation data at 12 months were available. Prior to contraception initiation, participants were asked to qualify their menstrual bleeding over the past year as: light, moderate, moderately heavy, or heavy. Light bleeding corresponded to using 10 pads/tampons per period. Moderate, moderately heavy, and heavy bleeding corresponded to 11e20 pads/tampons, 21e30 pads/tampons, and >30 pads/tampons per period, respectively. Subjects were then categorized into either a "heavy" baseline group (those reporting moderately heavy or heavy bleeding at baseline), or a "not heavy" group (those reporting light or moderate bleeding). The 12-month continuation rate for each group was then calculated using Kaplan-Meier survival function, and hazard ratio for risk of discontinuation was evaluated using a Cox proportional hazard model to determine if moderately heavy or heavy bleeding at baseline was associated with early discontinuation. RESULTS: Of the 918 girls and women meeting the inclusion criteria for this analysis, 165 were in the heavy baseline bleeding group, while 753 were in the not heavy bleeding group. The 12-month continuation rates for groups were similar: 80.2% (heavy) and 85.0% (not heavy; P ¼ .24). Patients reporting either moderately heavy or heavy baseline bleeding were not at increased risk for early discontinuation of copper intrauterine device (hazard ratio, 1.21; 95% confidence interval, 0.88e1.66). Our sample size provided >90% power to detect a clinically important difference of 15% (assuming 20% discontinuation rate in not heavy bleeding group and a 35% discontinuation rate in the heavy bleeding group). CONCLUSION: We did not find that girls and women who reported baseline moderately heavy or heavy menstrual bleeding were at increased risk for early discontinuation. Thus, we do not believe that girls and women with heavy menstrual bleeding should be discouraged from using this safe and highly effective form of contraception.
Introduction
Recent reports have documented significant declines in teen pregnancy and abortions in the United States.
1,2 One proposed explanation for this decrease is the increased use of the most effective methods of contraception: long-acting reversible contraception (LARC). 3 Intrauterine devices (IUDs) constitute the predominant form of LARC, with an estimated 4.4 million users (10.4% of total contraceptive use) in the United States. 4 These devices demonstrate low failure rates in tandem with high continuation rates. The copper IUD, for example, has a first-year unintended pregnancy rate of 0.8% with 12-month and 24-month continuation rates of 85% and 77%, respectively. 5, 6 IUDs are cost-effective as well. One analysis found that, over a 5-year period, the costeffectiveness of IUDs and vasectomy were similar when taking into account both method cost and the cost of unintended pregnancy. 5 The copper IUD was originally introduced in the 1970s. This device has a long history of being both safe and effective. 7 In addition to its low failure rate, the copper IUD offers a hormone-free, reversible contraceptive option, and is currently approved for up to 10 years of use in the United States. However, heavy menstrual bleeding is one of the most common side effects of the copper IUD resulting in device removal. 8 The objective of this study was to evaluate if there was an association between baseline heavy menstrual bleeding and early copper IUD removal. Our hypothesis was that women with a pattern of heavy menses prior to insertion were more likely to discontinue a copper IUD within 12 months.
Materials and Methods
We performed a secondary analysis of the Contraceptive CHOICE Project to evaluate the effect of baseline menstrual bleeding on copper IUD continuation. CHOICE was a prospective observational cohort study conducted from 2007 through 2013. The project offered 2e3 years of contraception at no cost to participants in an attempt to promote use of the most effective methods of contraception to reduce unintended pregnancies in the St Louis region. All Food and Drug Administrationeapproved methods of reversible contraception were offered to study participants. Methods were introduced in order of effectiveness; LARC Eligible girls and women were between the ages of 14e45 years, sexually active with a male partner (or soon to be), and currently either not using any form of contraception or willing to initiate a new form of reversible contraception. Participants were recruited from a variety of settings (eg, abortion clinics, university-based research clinics, ambulatory clinics) and included students, girls and women of all income and socioeconomic strata, postabortion and postpartum patients, and friends and acquaintances of participants.
Study participants underwent an initial in-person interview to collect baseline demographic, reproductive, and medical data. Participants were asked questions pertaining to menstrual history as part of the baseline survey. Subjects were asked to categorize their baseline menstrual bleeding as light (using 10 pads/tampons per period), moderate (11e20 pads/ tampons), moderately heavy (21e30 pads/tampons), heavy (>30 pads/tampons), or too variable or irregular to say. These responses provided the foundation for our analysis. Of note, only 2 women (0.2% of participants choosing copper IUD) reported bleeding as too variable or too irregular to describe. These participants were therefore excluded from our analysis.
Our analysis focused on the association of baseline bleeding pattern on copper IUD discontinuation. Method continuation was monitored by periodic telephone surveys at 3 and 6 months following method initiation, and then for every 6 months of participation in the project. The primary outcome of our study was discontinuation at 12 months from the time of initiation. Girls and women who chose copper IUD at enrollment and had method use data to determine continuation status by 12-month survey were included in this analysis.
Prior to statistical analysis, we evaluated the distribution of baseline bleeding patterns. Due to the small number of participants citing heavy baseline bleeding, we combined the moderately heavy and heavy bleeding groups into our "heavy" baseline bleeding group, and included the light and moderate bleeding groups into the "not heavy" group. Means and SD, or frequencies and percentages, were used to describe demographic characteristics of participants based on the data type, and c 2 test or t test were used to compare the participant characteristics between the heave group and not heavy group. A survival analysis approach was applied where the outcome event was defined as copper IUD discontinuation, and time to event was defined as the time period from method initiation to the time point when the participant discontinued copper IUD.
If the participant was lost to follow-up, she was censored at her last time of contact. Participants were censored if the contraceptive method was discontinued to attempt pregnancy. The Kaplan-Meier survival curve was calculated and was used to estimate the 12-month continuation/discontinuation rates. A Cox proportional hazard model was used to estimate the association between baseline bleeding pattern and 12-month discontinuation. We considered a covariate a confounder if it changed the effect estimate by !10% when the covariate was added to the model. Effect modification was assessed by evaluating the significance of the interaction term between the covariate and bleeding pattern in the model. A P value of <.05 was considered statistically significant. Software (Stata, Version 11; StataCorp, College Station, TX) was used for all analyses.
Since this was a secondary analysis of an existing data set, we did not do an a priori power/sample size analysis. However, our post hoc power analysis revealed a >90% power to detect a clinically important difference of 15% (assuming 20% discontinuation rate in not heavy bleeding group and a 35% discontinuation rate in the heavy bleeding group) based on our sample size.
Results
A total of 1102 study participants initially chose a copper IUD for contraception, 918 (83.3%) with clearly described bleeding pattern except too variable or too irregular and had continuation data available at 12 months. Of these 918 subjects, 165 reported either moderately heavy (n ¼ 141) or heavy (n ¼ 24) bleeding prior to IUD insertion, and thus constituted the heavy baseline bleeding group. The remaining 753 copper IUD users reported either light (n ¼ 192) or moderate (n ¼ 561) baseline bleeding and therefore were placed in the not heavy group (Figure 1) . The baseline demographic and reproductive characteristics of our sample of copper IUD users stratified by baseline bleeding pattern are provided in the Table. Subjects in the heavy bleeding group were more likely to be obese and to have a history of a sexually transmitted infection than participants in the not heavy group. There were no significant differences in age, race, education, marital status, socioeconomic status, insurance, or other baseline characteristics when we compared the 2 groups.
At 12 months from the time of copper IUD initiation, participants in the heavy and the not heavy baseline bleeding groups had similar continuation rates: 80.2% and 85.0%, respectively (P ¼ .24) (Figure 2 ). Patients in the heavy bleeding group were not at increased risk for early discontinuation (hazard ratio, 1.21; 95% confidence interval, 0.88e1.66). None of the participant variables listed in the Table were determined to be confounders or effect modifiers; therefore, a multivariable analysis was not performed.
Comment
The goal of our study was to assess if girls and women with baseline heavy menstrual bleeding were more likely to discontinue copper IUD at 1 year as compared to girls and women without heavy bleeding. Our analysis, however, did not show a significant relationship between baseline heavy menstrual bleeding and discontinuation of copper IUD at 1 year. This was somewhat surprising because, as previously mentioned, heavy bleeding is one of the most common side effects cited for early copper IUD discontinuation. 8, 9 Of note, our hypothesis was that girls and women with heavy baseline bleeding would be at increased risk of copper IUD discontinuation. This was based on the premise that any further bleeding caused by the device would prompt its removal. It is possible, however, that individuals with heavy baseline bleeding could be more tolerant of the bleeding associated with copper IUD, and therefore less likely to discontinue use of this device.
We attempted to compare the results of our study with existing data pertaining to the relationship between baseline Although not formally discussed in the report, menstrual flow prior to IUD insertion (ie, "usual" vs "more than usual") can be found in the table of patient characteristics. The tabulated crude odds ratio (odds ratio, 1.1; 95% confidence interval, 0.5e2.2) did not indicate a significant relationship between bleeding and discontinuation. 10 However, the study was also likely underpowered to evaluate this relationship given the low number of girls and women reporting heavy baseline bleeding.
Additional studies were identified that examined patient characteristics and personal reasons associated with copper IUD discontinuation, however baseline menstrual bleeding was not among the factors evaluated.
11,12 Stanback and Grimes 13 did examine the effect of bleeding on copper IUD discontinuation; however, in their study the assessment of bleeding occurred 1 month after IUD insertion. Therefore, this study did not provide a direct comparison for our analysis, which sought to investigate the relationship of bleeding prior to insertion.
One strength of our study is a reasonably large sample size of copper IUD users from a prospective cohort study of a diverse sample of participants. Data were generated using a standardized patient survey, and longitudinal follow-up included assessment of method discontinuation supplemented with medical record review. Less than 20% of copper IUD users were lost to follow-up at 12 months.
Despite the overall large number of CHOICE subjects selecting copper IUD, the greatest limitation of our analysis was the small number of participants reporting heavy baseline bleeding (n ¼ 24). We did, however, have >140 participants who stated their baseline bleeding pattern was moderately heavy. It is possible the low number of participants in the heavy bleeding category was the result of either patients or providers choosing not to use copper IUD in the setting of reported heavy baseline bleeding, given the concern for increased bleeding and subsequent early discontinuation. This low number of heavy bleeders limited our power to assess copper IUD continuation rates based Original Research GYNECOLOGY ajog.org upon the original 4 categories of bleeding. Thus, the power of our study to assess this group is limited, and there is a possibility of a type II error. While our data set was considered a strength of this study, the subjective nature of the data itself (ie, self-reported bleeding) could also be perceived as a limitation. Patient-reported menstrual bleeding patterns have long been shown to correlate poorly with objective measures of menorrhagia.
14 Reporting of pad or tampon usage (which defined each of the original subgroups) is also likely prone to recall bias. Further, variability likely exists with regards to how often pads/tampons are replaced, or to what degree products are soiled prior to changing. Despite these limitations, we must keep in mind that it is the patient's perception of heavy bleeding that can both influence contraceptive counseling and thus limit the use of the copper IUD.
Copper IUDs are safe, highly effective, and have a long and successful track record. 7 In addition to providing a nonhormonal option for contraception, the copper IUD also has the longest FDA-approved duration of use of all forms of reversible contraception. Further, some girls and women hold a desire to maintain monthly menses. Morrison et al 15 reported that the majority of girls and women (83%) in their survey viewed menstruation as natural, while only 32% viewed it as a "curse."
Unfortunately, IUD use in general is significantly lower in the United States when compared to many other countries. IUDsemostly copperecomprise an estimated 22.8% of contraceptive methods used worldwide, and yet only 6.1% in North America. 16 Much of this discord likely stems from counseling provided by medical providers. For example, Dehlendorf et al 17 found that, during contraception counseling visits, providers were least likely to recommend the copper IUD. Another study concluded that providers do not routinely prepare patients interested in copper IUD for the possibility of increased menstrual bleeding, thereby setting the stage for dissatisfaction with the device. 18 There also seems a paucity of guidance in managing increased bleeding associated with the initiation of a copper IUD, which has been shown to both diminish with time and be responsive to medical therapy. 19 In summary, the copper IUD is a safe and highly effective method of contraception. Many clinicians may have a bias against copper IUD use due to concerns for increased bleeding, especially in girls and women with preexisting heavy menses. Our analysis, however, did not demonstrate a correlation between early copper IUD discontinuation and heavy baseline menstrual bleeding. Incorporating this information, along with the other proven benefits of LARC, into contraceptive counseling may improve utilization rates of the copper IUD. n
